Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 28, 2016; 22(44): 9734-9743
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9734
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9734
Table 3 Multivariate logistic model for inflammatory bowel disease patients vs healthy controls in the presence of antibiotics and muramyl dipeptide stimulation
Variables | OR | 95%CI | P value | Regression coefficients |
MCP1 | 0.997248 | 0.995067-0.999434 | 0.014 | -0.0027555 |
IL8 | 1.000094 | 1.000019-1.000170 | 0.014 | 0.0000944 |
IL10 | 1.098966 | 1.009008-1.196944 | 0.030 | 0.0943694 |
Constant | 0.529026 | 0.108222-2.586054 | 0.432 | -0.636717 |
- Citation: Loganes C, Valencic E, Pin A, Marini E, Martelossi S, Naviglio S, De Leo L, Not T, Monasta L, Tommasini A, Marcuzzi A. Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease. World J Gastroenterol 2016; 22(44): 9734-9743
- URL: https://www.wjgnet.com/1007-9327/full/v22/i44/9734.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i44.9734